Monte Rosa Therapeutics
GLUE
#6712
Rank
โ‚ฌ0.67 B
Marketcap
7,88ย โ‚ฌ
Share price
-3.03%
Change (1 day)
-36.21%
Change (1 year)

EPS for Monte Rosa Therapeutics (GLUE)

EPS in 2026 (TTM): -1,47ย โ‚ฌ

According to Monte Rosa Therapeutics's latest financial reports the company's current EPS (TTM) is -1,55ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -0,70ย โ‚ฌ an increase over its 2024 EPS that were of -0,94ย โ‚ฌ.

EPS history for Monte Rosa Therapeutics from 2022 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-1,47ย โ‚ฌ109%
2025-0,70ย โ‚ฌ-25.22%
2024-0,94ย โ‚ฌ-60.93%
2023-2,41ย โ‚ฌ15.28%
2022-2,09ย โ‚ฌ